EC
EcoR1 Capital, LLC disclosed a 8.6% stake in ETON
EcoR1 Capital, LLC reported owning 8.6% of Eton Pharmaceuticals, Inc. (ETON) (2,470,920 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G